These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 836561)

  • 41. The aminopyrine breath test does not correlate with histologic disease severity in patients with cholestasis.
    Baker AL; Krager PS; Kotake AN; Schoeller DA
    Hepatology; 1987; 7(3):464-7. PubMed ID: 3570158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance.
    Schnegg M; Lauterburg BH
    J Hepatol; 1986; 3(2):164-71. PubMed ID: 3794298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The aminopyrine breath test for the evaluation of liver function in alcoholic patients: drug pharmacokinetics and environmental factors.
    Lane EA
    Adv Alcohol Subst Abuse; 1988; 7(3-4):25-32. PubMed ID: 3146921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of cyclosporine A on the demethylation of aminopyrine in rats in vivo.
    Beckurts KT; Lauterburg BH
    Eur Surg Res; 1995; 27(2):111-6. PubMed ID: 7781642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocyte mass.
    Gross JB; Reichen J; Zeltner TB; Zimmermann A
    Hepatology; 1987; 7(3):457-63. PubMed ID: 3570157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of hepatic tetrahydrofolate and inhibition of exhalation of 14CO2 formed from [dimethylamino-14C]aminopyrine in nitrous oxide-treated rats.
    Black KA; Virayotha V; Tephly TR
    Hepatology; 1984; 4(5):871-6. PubMed ID: 6434391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of variation in dietary protein and ethanol on hepatic microsomal drug metabolism in the rat.
    Mitchell MC; Mezey E; Maddrey WC
    Hepatology; 1981; 1(4):336-40. PubMed ID: 7197255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic metabolism of aminopyrine in patients with chronic renal failure.
    Scherrer S; Haldimann B; Küpfer A; Reubi F; Bircher J
    Clin Sci Mol Med; 1978 Feb; 54(2):133-40. PubMed ID: 620502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The determination of aminopyrin elimination for control of the metabolic capacity of the liver in man.
    Haustein KO; Hüller G; Sensing H
    Eur J Clin Invest; 1982 Apr; 12(2):157-64. PubMed ID: 6807687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of propyphenazone on drug biotransformation in the liver. A comparison with phenylbutazone using the aminopyrine breath test].
    Reinicke C; Clemens M; Steiner A; Stiller KJ; Tanner E; Wächter G
    Z Gesamte Inn Med; 1988 Feb; 43(4):80-3. PubMed ID: 3259761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The 30-minute aminopyrine breath test: optimization of sampling times after intravenous administration of 14C-aminopyrine.
    Miotti T; Bircher J; Preisig R
    Digestion; 1988; 39(4):241-50. PubMed ID: 3220177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Increased demethylation of aminopyrine under long-term treatment with anticonvulsive drugs (author's transl)].
    Caspary WF; Schäffer J
    Klin Wochenschr; 1978 Jul; 56(13):677-9. PubMed ID: 97469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hepatic clearance of aminopyrine in the evaluation of liver function in hormonal contraception].
    Sensing H; Haustein KO; Hüller G
    Z Gesamte Inn Med; 1983 Dec; 38(23):622-6. PubMed ID: 6670337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The aminopyrine breath test, an inadequate early indicator of methotrexate-induced liver disease in patients with psoriasis.
    Williams CN; McCauley D; Malatjalian DA; Turnbull GK; Ross JB
    Clin Invest Med; 1987 Mar; 10(2):54-8. PubMed ID: 3581546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of drug metabolism by cimetidine in man: dependence on pretreatment microsomal liver function.
    Röllinghoff W; Paumgartner G
    Eur J Clin Invest; 1982 Oct; 12(5):429-32. PubMed ID: 6816615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 13C-aminopyrine demethylation is decreased in cirrhotic patients with normal biochemical markers.
    Afolabi P; Wright M; Wootton SA; Jackson AA
    Isotopes Environ Health Stud; 2013; 49(3):346-56. PubMed ID: 23799253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aminopyrine N-demethylation by rats with liver cirrhosis. Evidence for the intact cell hypothesis. A morphometric-functional study.
    Reichen J; Arts B; Schafroth U; Zimmermann A; Zeltner B; Zysset T
    Gastroenterology; 1987 Oct; 93(4):719-26. PubMed ID: 3623018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatic oxidative drug metabolism and the microsomal milieu in a rat model of congenital hyperbilirubinemia.
    Meredith CG; Muhoberac BB; Gray JP; Speeg KV; Dunn D; Hoyumpa AM; Schenker S
    Biochem Pharmacol; 1986 Nov; 35(21):3831-7. PubMed ID: 3778508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of the [14C]aminopyrine breath test to assess the hepatic response of dietary obese rats to a very-low-energy diet.
    Young EA; Harris MM; Cantu TL; Deneke SM; Schenker S
    Am J Clin Nutr; 1993 Jun; 57(6):863-7. PubMed ID: 8503354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of aminopyrine metabolism in man by breath analysis after oral administration of 14C-aminopyrine. Effects of phenobarbital, disulfiram and portal cirrhosis.
    Hepner GW; Vesell ES
    N Engl J Med; 1974 Dec; 291(26):1384-8. PubMed ID: 4427643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.